Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients

NCT00507442 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: VELCADE (bortezomib)
DRUG: dexamethasone
DRUG: cyclophosphamide
DRUG: Revlimid (lenalidomide)

Sponsor

Millennium Pharmaceuticals, Inc.

Collaborators

[object Object]